Related Experiment Video
Updated: May 30, 2026

07:57
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
Organ and effective doses from verification techniques in image-guided radiotherapy
1National Radiation Protection Institute, Bartoskova 28, 14000 Prague, Czech Republic. vladimir.dufek@suro.cz
Radiation Protection Dosimetry
|August 6, 2011
Summary
This study measured organ and effective doses from image-guided radiotherapy verification techniques. Kilovoltage cone beam CT and kV/MV imaging doses were evaluated for pelvis and head/neck sites.
Area of Science:
- Medical Physics
- Radiotherapy
- Radiation Dosimetry
Background:
- Image-guided radiotherapy (IGRT) is crucial for accurate treatment delivery.
- Verification imaging techniques in IGRT contribute to patient organ doses.
- Understanding these doses is essential for optimizing radiation safety in oncology.
Purpose of the Study:
- To evaluate organ doses and effective doses from three IGRT verification techniques.
- To compare doses from kilovoltage (kV) cone beam CT (CBCT), kV imaging, and megavoltage (MV) imaging.
- To assess doses for pelvis and head and neck (H&N) treatment sites.
Main Methods:
- Organ doses were measured using thermoluminescent dosemeters in a male anthropomorphic Rando phantom.
- Dose evaluations were performed for CBCT scans, two orthogonal kV images, and two orthogonal MV images.
- Prostate and H&N radiotherapy doses were assessed for comparative analysis.
Main Results:
- Pelvis kV imaging resulted in the lowest organ doses (0.05-1%) compared to CBCT (1-6%) and MV imaging (1-10%) relative to prostate radiotherapy.
- Maximum effective doses for pelvis imaging were 5.6 mSv (CBCT), 0.8 mSv (kV), and 11.9 mSv (MV).
Conclusions:
- Different IGRT verification methods yield varying organ and effective doses.
- kV imaging appears to deliver lower doses compared to CBCT and MV imaging for pelvis verification.
- Further research is needed to optimize IGRT protocols for dose reduction.
